EMBARGO UNTIL 12.00 noon, Tuesday 3 December Photo opportunity: A giant, walking alcohol bottle will attend the launch of the exhibition. It will also meet MEP Andriukaitis during the official launch (around 18.00) at the European Parliament, Altiero Spinelli Building,…
At the upcoming Extraordinary General Assembly, the EASL Governing Board will present an update on the 2024 activities and a forecast of the 2024 budget. Furthermore, the Governing Board will present the EASL strategy and activities for next year, as…
EASL has released its updated Clinical Practice Guidelines on Liver Transplantation (LT). The guidelines represent a significant overhaul, reflecting major advancements in the field since the last update in 2016. The field of liver transplantation (LT) has advanced significantly in…
We are excited to announce the launch of the call for nominations and applications for three prestigious awards: the EASL Community Award 2025, the EASL Emerging Leader Award 2025, and the EASL Nurses & Allied Health Professionals Rising Star Award…
The recipient of the 2024 Daniel Alagille Award, Sarina Shabso, discusses her inspiring journey into the field of hepatology. Shabso's path, from her early focus on skin regeneration to her groundbreaking research on genetic cholestatic diseases, showcases her dedication and…
In an insightful conversation with EASL, Scott Waddell, the recipient of the 2023 Daniel Alagille Award, shares his journey into the field of hepatology. From his initial focus on cholangiocarcinoma to his pioneering work on polycystic liver disease, Waddell's dedication…
The EASL Educational Committee provides scientific expertise and support to the EASL Governing Board and EASL office, in the development and monitoring of a high-quality portfolio of educational offerings in support of EASL’s educational strategy and commitment to remaining a…
The EMA human medicines committee (CHMP) has recently issued a statement on Obeticholic acid for the treatment of Primary Biliary Cholangitis (PBC). The CHMP recommended to the European Commission that the market authorisation for Obeticholic acid in the European Union…
• First patient enrolled at Hôpital Beaujon, Clichy, France • The COMBAT Trial is a multicenter, randomized, open-label, Phase II clinical trial in patients with decompensated cirrhosis Barcelona, Spain, 9th July 2024 – DECISION, an EU-funded research consortium in liver…
The European Association for the Study of the Liver (EASL)is delighted to announce that JHEP Reports, its Open Access publication, achieved an impressive impact factor of 9.5 in the 2024 release of Journal Citation Reports (JCR) by Clarivate. This notable…